Ernexa Therapeutics Inc. Warrants (ERNAW) Stock Price

ERNAWStock
$0.05
Market Cap
P/E
PEG Ratio
Div yield
Beta

ERNAW Share Price Chart

Favorite Metrics

Price vs S&P 500 (4W)7.15%
VGM Score89.15

Industry Peers — Pharmaceuticals(571)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
ERNAWErnexa Therapeutics Inc. Warrants
A$0.05
LLYEli Lilly & Co.DBB$1233.66
JNJJohnson & JohnsonDCB$273.14
ABBVABBVIE INC.DCB$265.79
MRKMerck & Co., Inc.DCA$156.45
NVSNovartis AGCCC$159.98
AZNAstraZeneca PLCCBC$169.66
NVONovo-Nordisk A/SBCC$48.66
ABTAbbott LaboratoriesCCB$116.13
PFEPfizer Inc.CDC$28.57
VRTXVertex Pharmaceuticals IncDCB$552.85

About Ernexa Therapeutics Inc. Warrants

Ernexa Therapeutics develops cell-based medicines for cancer and autoimmune diseases using proprietary technology that transforms iPSCs into iMSCs. The platform generates off-the-shelf treatment solutions without patient-specific cell harvesting, potentially offering advantages in scalability and manufacturing efficiency.